Cafepharma Today

Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Moderna races to create norovirus vaccines
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Trump administration delays funding to cancer research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Bloomberg
Friday, January 23, 2009 - 7:50am
tags:
CNBC
Friday, January 23, 2009 - 7:49am
tags:
CNBC
Thursday, January 22, 2009 - 8:11pm
tags:
Fierce Pharma
Thursday, January 22, 2009 - 6:45pm
tags:
Fierce Pharma
Thursday, January 22, 2009 - 6:44pm
WSJ Online
Thursday, January 22, 2009 - 6:42pm
Phama Live
Thursday, January 22, 2009 - 3:41pm
WSJ Online
Thursday, January 22, 2009 - 3:39pm
tags:
CNBC
Thursday, January 22, 2009 - 3:34pm
RTT News
Thursday, January 22, 2009 - 11:20am
Pharma TImes, UK
Thursday, January 22, 2009 - 11:19am
TheStreet.com
Thursday, January 22, 2009 - 10:38am
Bizjournals.com
Thursday, January 22, 2009 - 10:35am
WSJ Online
Thursday, January 22, 2009 - 8:44am
PharmExec
Thursday, January 22, 2009 - 8:41am
PharmExec
Thursday, January 22, 2009 - 8:39am
tags:

Pages

Latest Jobs

Santa Monica, California
KARL STORZ Endoscopy - America
Fields, Oregon, 97710
CSL Behring
Tarrytown, New York
Lundbeck
Fields, Oregon, 97710
CSL Behring
Fields, Oregon, 97710
CSL Behring
Boise, Idaho, 83708
Bartlett Roofing
Carteret, New Jersey, United States
The Spear Group
Fields, Oregon, 97710
CSL Behring
Midland, Texas, 79701
Lundbeck
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.